title: Current developments, problems and solutions in the non-surgical treatment of pancreatic cancer.
abstract: Pancreatic cancer is a common malignant neoplasm of the pancreas with an increasing incidence, a low early diagnostic rate and a fairly poor prognosis. To date, the only curative therapy for pancreatic cancer is surgical resection, but only about 20% patients have this option at the time of diagnosis and the mean 5-year survival rate after resection is only 10%-25%. Therefore, developing new treatments to improve the survival rate has practical significance for patients with this disease. This review deals with a current unmet need in medical oncology: the improvement of the treatment outcome of patients with pancreatic cancer. We summarize and discuss the latest systemic chemotherapy treatments (including adjuvant, neoadjuvant and targeted agents), radiotherapy, interventional therapy and immunotherapy. Besides discussing the current developments, we outline some of the main problems, solutions and prospects in this field.
authors.affiliation: Xiao-Zhong Guo, Zhong-Min Cui, Xu Liu, Department of Gastroenterology, the General Hospital of Shenyang Military Command, Shenyang 100840, Liaoning Province, China.
authors.forename: Xiao-Zhong
authors.initials: XZ
authors.lastname: Guo
authors.forename: Zhong-Min
authors.initials: ZM
authors.lastname: Cui
authors.forename: Xu
authors.initials: X
authors.lastname: Liu
keywords: Immunotherapy; Interventional therapy; Pancreatic cancer; Radiotherapy; Survival rate; Systemic chemotherapy; Treatment
references.citation: JOP. 2006 Mar 09;7(2):163-73
references.pmid: 16525200
references.citation: Gut. 2004 Mar;53(3):355-61
references.pmid: 14960515
references.citation: Gastrointest Endosc. 2005 May;61(6):746-52
references.pmid: 15855986
references.citation: Cancer Res. 2005 Nov 15;65(22):10371-80
references.pmid: 16288027
references.citation: Hepatobiliary Pancreat Dis Int. 2009 Oct;8(5):529-34
references.pmid: 19822498
references.citation: J Clin Oncol. 2005 Nov 1;23(31):8033-40
references.pmid: 16258101
references.citation: Cancer Treat Rev. 2009 Aug;35(5):431-6
references.pmid: 19328630
references.citation: Ann Oncol. 2004 Feb;15(2):224-9
references.pmid: 14760113
references.citation: JOP. 2007 Sep 07;8(5):545-52
references.pmid: 17873458
references.citation: J Clin Oncol. 2008 Jul 20;26(21):3503-10
references.pmid: 18640931
references.citation: J Clin Oncol. 2007 Oct 20;25(30):4787-92
references.pmid: 17947726
references.citation: Oncologist. 2005 Mar;10(3):183-90
references.pmid: 15793221
references.citation: Cancer Chemother Pharmacol. 2009 May;63(6):1141-5
references.pmid: 18839175
references.citation: Ai Zheng. 2008 Nov;27(11):1204-7
references.pmid: 19000454
references.citation: Gastrointest Endosc. 2008 May;67(6):961-3
references.pmid: 18440386
references.citation: Gastroenterology. 2009 May;136(5):1772-82
references.pmid: 19208367
references.citation: Oncology. 2005;69(5):421-7
references.pmid: 16319514
references.citation: JAMA. 2010 Sep 8;304(10):1073-81
references.pmid: 20823433
references.citation: Cardiovasc Intervent Radiol. 2007 Sep-Oct;30(5):912-21
references.pmid: 17710478
references.citation: Hepatogastroenterology. 2006 Jan-Feb;53(67):141-4
references.pmid: 16506394
references.citation: Radiother Oncol. 2009 Aug;92(2):238-43
references.pmid: 19454367
references.citation: J Hepatobiliary Pancreat Surg. 2009;16(5):592-7
references.pmid: 19547908
references.citation: Cancer. 2008 Oct 15;113(8):2046-52
references.pmid: 18756532
references.citation: J Mol Med (Berl). 2003 Jan;81(1):43-50
references.pmid: 12545248
references.citation: Lancet Oncol. 2008 Jan;9(1):39-44
references.pmid: 18077217
references.citation: Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1208-14
references.pmid: 18954714
references.citation: Clin Cancer Res. 2005 Oct 15;11(20):7532-7
references.pmid: 16243828
references.citation: J Clin Oncol. 2006 Aug 20;24(24):3946-52
references.pmid: 16921047
references.citation: Expert Rev Anticancer Ther. 2006 Mar;6(3):313-9
references.pmid: 16503848
references.citation: Cancer Chemother Pharmacol. 2006 Jan;57(2):185-90
references.pmid: 16151811
references.citation: Curr Drug Discov Technol. 2006 Dec;3(4):231-43
references.pmid: 17430101
references.citation: Jpn J Clin Oncol. 2009 Dec;39(12):797-806
references.pmid: 19797418
references.citation: Ann Oncol. 2007 Apr;18(4):745-51
references.pmid: 17229775
references.citation: Oncology. 2007;73(3-4):221-7
references.pmid: 18424886
references.citation: Br J Surg. 2009 Jan;96(1):5-20
references.pmid: 19016272
references.citation: Radiother Oncol. 2005 Jul;76(1):48-53
references.pmid: 15990186